Skip to main content

Table 2 Lipid-related parameters of placebo and test group at baseline and 12-week follow up

From: The cholesterol-lowering effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline-high cholesterol levels: a randomized controlled trial

  Placebo group (n = 38) uRC group (n = 39) Pa Pb Pc
Baseline Follow-up Baseline Follow-up
Total-cholesterol (mg/dL) 213.86 ±1.79 208.81 ±3.95 214.05 ±1.50 192.82 ±4.07 0.938 0.006  
Change   −5.05 ±3.84    −21.23 ±4.36     0.007
Triglyceride (mg/dL) 111.45 ±6.22 119.26 ±7.70 116.05 ±7.13 115.49 ±8.13 0.629 0.737  
Change   −7.82 ±7.84    --0.56 ±7.06     0.429
LDL-cholesterol (mg/dL) 135.60 ±2.58 132.55 ±4.26 133.41 ±2.06 117.79 ±4.34 0.508 0.018  
Change   −3.05 ±3.95    −15.61 ±4.16     0.032
Non-HDL-cholesterol (mg/dL) 153.71 ±3.13 147.03 ±4.33 153.41 ±2.63 133.28 ±4.40 0.942 0.029  
Change   −6.68 ±3.30    −20.13 ±4.14     0.013
Apolipoprotein B (mg/dL) 114.39 ±2.75 120.60 ±3.82 115.17 ±2.83 111.69 ±3.46 0.843 0.088  
Change   6.21 ±2.84    −3.48 ±3.40     0.032
Oxidized LDL (U/L) 68.05 ±3.02 66.09 ±3.47 64.31 ±2.53 57.76 ±2.07 0.348 0.044  
Change   −1.95 ±2.41    −6.23 ±1.96     0.174
  1. Mean ± SE (Standard Error), Pa-values derived from independent t-test at baseline baseline between the placebo and the uRC group. Pb-values derived from independent t-test at 12-week follow up between the placebo and the uRC group. Pc-values derived from independent t-test for changed value between the placebo and the uRC group. Change value (Δ, delta) represents the change from baseline at follow-up